R21/Matrix-M vaccine, developed by the University of Oxford, is the first malaria vaccine to reach 75% efficacy target
You must log in or register to comment.
R21/Matrix-M vaccine, developed by the University of Oxford, is the first malaria vaccine to reach 75% efficacy target